USD 0.0
(-99.67%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | -2.19 Million USD | 47.94% |
2022 | -4.21 Million USD | -128.33% |
2021 | 14.87 Million USD | 438.97% |
2020 | -4.38 Million USD | -134.36% |
2019 | 12.77 Million USD | 13.4% |
2018 | 11.26 Million USD | -14.54% |
2017 | 13.17 Million USD | 150.69% |
2016 | 5.25 Million USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | -100.0% |
2009 | 308.47 USD | -69.38% |
2008 | 1007.40 USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | -466 Thousand USD | -10.43% |
2024 Q2 | -228 Thousand USD | 51.07% |
2023 Q3 | -574 Thousand USD | 69.12% |
2023 FY | -2.19 Million USD | 47.94% |
2023 Q1 | 179 Thousand USD | 103.44% |
2023 Q2 | -1.85 Million USD | -1138.55% |
2023 Q4 | -422 Thousand USD | 26.48% |
2022 Q2 | -2.35 Million USD | -386.04% |
2022 Q3 | -451 Thousand USD | 80.87% |
2022 Q4 | -5.2 Million USD | -1052.99% |
2022 Q1 | 824 Thousand USD | -84.44% |
2022 FY | -4.21 Million USD | -128.33% |
2021 Q4 | 5.29 Million USD | 23.42% |
2021 Q2 | 3.05 Million USD | 36.68% |
2021 Q3 | 4.29 Million USD | 40.63% |
2021 FY | 14.87 Million USD | 438.97% |
2021 Q1 | 2.23 Million USD | -28.29% |
2020 Q2 | -11.77 Million USD | -563.22% |
2020 Q4 | 3.11 Million USD | 79.9% |
2020 FY | -4.38 Million USD | -134.36% |
2020 Q1 | 2.54 Million USD | 149.38% |
2020 Q3 | 1.73 Million USD | 114.7% |
2019 Q3 | 6.67 Million USD | 0.47% |
2019 Q4 | -5.14 Million USD | -177.11% |
2019 FY | 12.77 Million USD | 13.4% |
2019 Q1 | 4.59 Million USD | 237.97% |
2019 Q2 | 6.64 Million USD | 44.54% |
2018 Q1 | 4.76 Million USD | 155.53% |
2018 FY | 11.26 Million USD | -14.54% |
2018 Q4 | -3.33 Million USD | -168.28% |
2018 Q3 | 4.87 Million USD | -1.45% |
2018 Q2 | 4.95 Million USD | 3.96% |
2017 Q3 | 7.03 Million USD | 106.98% |
2017 Q4 | -8.57 Million USD | -221.94% |
2017 Q1 | 3.38 Million USD | 7.09% |
2017 FY | 13.17 Million USD | 150.69% |
2017 Q2 | 3.39 Million USD | 0.49% |
2016 Q4 | 3.15 Million USD | -3.13% |
2016 Q1 | -512.00 USD | 0.0% |
2016 FY | 5.25 Million USD | 0.0% |
2016 Q2 | 692.55 Thousand USD | 135364.84% |
2016 Q3 | 3.25 Million USD | 370.6% |
2015 Q3 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 FY | - USD | -100.0% |
2010 Q4 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q1 | - USD | -100.0% |
2009 FY | 308.47 USD | -69.38% |
2009 Q4 | 6.29 USD | 0.0% |
2009 Q3 | - USD | -100.0% |
2009 Q2 | 100.78 USD | -38.23% |
2009 Q1 | 163.14 USD | -57.61% |
2008 FY | 1007.40 USD | 0.0% |
2008 Q3 | 600.79 USD | 2558.64% |
2008 Q2 | 22.60 USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 Q4 | 384.87 USD | -35.94% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
American Oncology Network, Inc. | 66.05 Million USD | 103.321% |
ATI Physical Therapy, Inc. | 96.8 Million USD | 102.266% |
Novo Integrated Sciences, Inc. | 4.95 Million USD | 144.299% |
Panamera Holdings Corporation | 5372.00 USD | 40941.4% |